Ascend Gene & Cell Therapies is a gene and cell therapy manufacturing specialist that has recently secured a significant £106 million Series A funding round. The company aims to improve therapies by constantly refining and innovating its approach, with a focus on creating effective gene therapies to a world-class standard. Ascend supports manufacturing and process development projects from design through to clinical and commercial scales, and it prioritizes communication, transparency, and building lasting trust with its partners.

Ascend Gene & Cell Therapies

Workable provides recruiting software and a hiring platform that allows users to find, hire, onboard, and manage employees.

COM:ASCEND-GCTX

Workable